{"title":"Differences between Hyperprogressive Disease and Progressive Disease in Patients Receiving Immunotherapy","authors":"H. Yıldırım","doi":"10.14744/ejmo.2022.78280","DOIUrl":null,"url":null,"abstract":"DOI: 10.14744/ejmo.2022.78280 EJMO 2022;6(1):59–63 Eurasian Journal of Medicine and Oncology","PeriodicalId":11831,"journal":{"name":"Eurasian Journal of Medicine and Oncology","volume":"40 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eurasian Journal of Medicine and Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14744/ejmo.2022.78280","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
Abstract
DOI: 10.14744/ejmo.2022.78280 EJMO 2022;6(1):59–63 Eurasian Journal of Medicine and Oncology
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
